We can conclude that in NPC, ARHGAP35 can act codownstream of both FTO and ALKBH5 and promote the proliferation and migration of NPC cells through the FTO/ALKBH5-ARHGAP35 axis (Fig. 8). The gene discussed is ARHGAP35; the disease is nasopharyngeal carcinoma.